AXQ Capital LP Purchases 17,437 Shares of Oscar Health, Inc. $OSCR

AXQ Capital LP increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 168.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 27,759 shares of the company’s stock after purchasing an additional 17,437 shares during the period. AXQ Capital LP’s holdings in Oscar Health were worth $595,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in OSCR. Thrive Capital Management LLC grew its stake in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Cerity Partners LLC purchased a new stake in shares of Oscar Health in the first quarter worth about $132,000. CWM LLC grew its stake in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after purchasing an additional 1,078 shares during the period. Victory Capital Management Inc. grew its position in Oscar Health by 23.8% during the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company’s stock valued at $3,749,000 after buying an additional 54,938 shares during the period. Finally, Kestra Private Wealth Services LLC acquired a new position in Oscar Health in the 1st quarter worth about $157,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Trading Up 3.3%

NYSE OSCR opened at $13.46 on Friday. The stock has a market capitalization of $3.56 billion, a P/E ratio of -12.02 and a beta of 1.88. The firm has a 50-day moving average price of $18.26 and a 200 day moving average price of $16.92. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The firm had revenue of $2.93 billion for the quarter, compared to analyst estimates of $3.09 billion. During the same quarter in the prior year, the company posted ($0.22) earnings per share. Oscar Health’s quarterly revenue was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. Equities research analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Buying and Selling at Oscar Health

In related news, insider Mario Schlosser sold 286,182 shares of Oscar Health stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the completion of the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $7,652,529.96. The trade was a 36.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. 24.39% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on OSCR. Barclays lifted their price target on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a research note on Monday, November 10th. Wall Street Zen raised Oscar Health from a “sell” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. UBS Group boosted their price target on shares of Oscar Health from $11.00 to $12.00 and gave the stock a “sell” rating in a research note on Friday, November 7th. Finally, The Goldman Sachs Group assumed coverage on shares of Oscar Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target for the company. Six analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $13.14.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.